slide1
Download
Skip this Video
Download Presentation
Data on burden of pneumonia in the country is limited

Loading in 2 Seconds...

play fullscreen
1 / 21

Data on burden of pneumonia in the country is limited - PowerPoint PPT Presentation


  • 127 Views
  • Uploaded on

Data on burden of pneumonia in the country is limited. Top Killer of Children: Pneumonia. Maria Rosario Z. Capeding, M.D. Research Institute for Tropical Medicine. Pneumonia remains to be a major cause of morbidity and mortality among Filipino children. Pneumonia Morbidity Rate by Region

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Data on burden of pneumonia in the country is limited' - doctor


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
top killer of children pneumonia

Top Killer of Children: Pneumonia

Maria Rosario Z. Capeding, M.D.

Research Institute for Tropical Medicine

slide5
Pneumonia Morbidity Rate by Region

Rate per 100,00 population

CAR: 1750

Region II: 600

Region I: 400

Region III: 250

Region V: 3200

NCR: 450

Region IV-A: 700

Region VIII: 1400

Region IV-B: 350

CARAGA: 450

Region VI: 900

Region X: 600

Region VII: 800

Region XII: 1200

Region IX: 650

Region XI: 1300

2008

ARMM:

active hospital based surveillance study of ipd and pneumonia among urban children 2007 2009
Active Hospital-based Surveillance Study of IPD and Pneumonia Among Urban Children (2007-2009)

Bravo, Santos, Capeding et al

Submitted for Publication

risk factors for pneumonia
Risk factors for Pneumonia:

Rudan et al. WHO Bulletin 2008 May 2008, vol 86 no 5; Pneumonia: The Forgotten Killer of Children Unicef/WHO 2006

outcome of childhood pneumonia evrmc 2008 2011
Outcome of Childhood Pneumonia EVRMC 2008-2011

Lupisan et al Asia-Africa Congress on Emerging and Re-emerging Infections

Kobe, Japan January 2012

etiology of pneumonia in 5 years old 1984 1986 ritm n 537
Etiology of Pneumonia in <5 Years Old 1984-1986, RITM, N=537

Pre Hib/PCV Era

RSV

37%

Parainfluenza

17%

Adenov 13%

S. pneumo

15%

Mixed

Viral/bacterial

23%

H

influenzae

21%

Others

17%

S

typhi

14%

Lucero, et al. Reviews InfDis 1990

slide12
Etiology of Pneumonia in <5 Years Old 1990-1992, RITM, N=332

Pre Hib/PCV Era

Bacterial Pathogens

S. aureus

K. pneumoniae

S. viridans

A. anitratum

Viral Pathogens

Parainfluenza

Influenza A and B

Capeding et al. Etiology of ALRI in Filipino Children under 5 years

Southeast Asian J Trop Med Public Health, Dec. 1994

slide13
Etiology of Pneumonia in <5 Years Old 2008-2011, EVRMC N=1582

Hib/PCV Era

S. pneumoniae

H. influenzae

Others

S. aureus

MRSA

S. typhi

RSV 14%

Rhino-A 7%

Rhino-C 6%

hMPV* 3.3%

Others

Influenza A (H1N1)

Influenza A/B

Adenovirus

Parainfluenza

Lupisan et al Asia-Africa Congress on Emerging and Re-emerging Infections

Kobe, Japan January 2012

determining bacterial etiology in childhood pneumonia is challenging
Determining Bacterial Etiology in Childhood Pneumonia is Challenging
  • Use of conventional bacterial culture considered as gold standard but with low sensitivity
  • Bacteria (S. pneumoniae, H. influenzae) are fastidious organisms
  • High percentage of antibiotic usage prior to hospitalization
mortality rate by case definitions evrmc
Mortality Rate by Case Definitions EVRMC

Total number of cases = 108

empiric antibiotic treatment
Empiric Antibiotic Treatment
  • PCAP A or B without previous antibiotic
      • Oral amoxicillin, drug of choice
  • PCAP C without previous antibiotic and complete Hib vaccination.
      • Penicillin G, drug of choice
  • PCAP C with incomplete Hib vaccination
          • Ampicillin IV
  • PCAP D
          • Refer to Specialist

CPG, In the Evaluation and Management of Pediatric Community Acquired Pneumonia

percent resistance of s pneumoniae jan dec 2010
Percent Resistance of S. pneumoniaeJan-Dec 2010

% RESISTANCE

CHL=ChloramphenicolPEN=Penicillin SXT=Cotrimoxazole

*%R(N)

ARSP Report 2010

clinical management of viral etiology
Clinical Management of Viral Etiology
  • In laboratory confirmed influenza A or B virus infection.
      • Influenza A: amantadine for 3-5 days, an option to discontinue within 24-48 hours after resolution of symptoms
      • Influenza A or B: oseltamivir for 5 days
  • Both drugs should be administered within 48 hours of onset of symptoms, ineffective against respiratory viruses other than influenza, not recommended for children below 1 year old

CPG, In the Evaluation and Management of Pediatric Community Acquired Pneumonia

burden of pneumonia over the past decades
Burden of Pneumonia Over the Past Decades
  • Pneumonia is the most common presentation of IPD in children.
  • Most commonly affects the very young
  • S. pneumoniae, H. influenzaeand RSV consistently are the most frequently detected pathogens
  • Pneumonia is the top killer of Filipino children <5 years old, accounts for 34% of deaths

the

90’s

ad